Q3 2016 Holdings
Filed 2016-11-14 | 134 holdings | $2.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Concert Pharmaceuticals, Inc.(CNCEEUR) | COM | 206022105 | $3.2K | 316,976 | 0.0% |
| Sunesis Pharmaceuticals, Inc. | COM PAR | 867328700 | $3.2K | 741,665 | 0.0% |
| Array BioPharma Inc. Notes 3.0% 6/1/2020 | NOTE 3.0% 6/1/2020 | 04269XAA3 | $3.6K | $3,000,000 | 0.0% |
| Ignyta, Inc. | COM | 451731103 | $3.6K | 571,000 | 0.0% |
| Loxo Oncology, Inc. | COM | 548862101 | $3.6K | 137,735 | 0.0% |
| Stemline Therapeutics, Inc. | COM | 85858C107 | $3.6K | 333,497 | 0.0% |
| Minerva Neurosciences, Inc.(NERVGBP) | COM | 603380106 | $3.7K | 258,805 | 0.0% |
| Akari Therapeutics plc | SPONSORED ADR | 00972G108 | $4.2K | 496,901 | 0.0% |
| Medgenics, Inc. | COM NEW | 58436Q203 | $4.9K | 880,539 | 0.0% |
| Natera, Inc.(NTRA) | COM | 632307104 | $5.0K | 450,000 | 0.0% |
| NeuroDerm Ltd. | ORD SHS | M74231107 | $5.6K | 305,000 | 0.0% |
| ProQR Therapeutics N.V. | SHS EURO | N71542109 | $5.7K | 860,464 | 0.0% |
| Alcobra Ltd. | SHS | M2239P109 | $5.8K | 2,336,359 | 0.0% |
| Insmed Incorporated(INSM) | COM PAR $.01 | 457669307 | $5.8K | 400,000 | 0.0% |
| Trillium Therapeutics Inc. | COM NEW | 89620X506 | $6.1K | 413,697 | 0.0% |
| Inotek Pharmaceuticals Corporation Notes 5.75% 8/1/2021 | NOTE 5.75% 8/1/2021 | 45780VAB8 | $6.7K | $5,000,000 | 0.0% |
| Ultragenyx Pharmaceutical Inc.(RARE) | COM | 90400D108 | $7.1K | 100,000 | 0.0% |
| Alder BioPharmaceuticals, Inc.(ALDR1EUR) | COM | 014339105 | $7.1K | 217,328 | 0.0% |
| Ligand Pharmaceuticals Incorporated(LGND) | COM NEW | 53220K504 | $7.5K | 73,386 | 0.0% |
| ImmunoGen, Inc.(IMGNEUR) | COM | 45253H101 | $8.1K | 3,015,353 | 0.0% |
| Intra-Cellular Therapies, Inc.(ITCIEUR) | COM | 46116X101 | $9.3K | 609,166 | 0.0% |
| Sage Therapeutics, Inc.(SG7) | COM | 78667J108 | $9.6K | 208,328 | 0.0% |
| Dimension Therapeutics, Inc. | COM | 25433V105 | $10.0K | 1,251,881 | 0.0% |
| ContraFect Corporation(CFRXEUR) | COM | 212326102 | $10.0K | 4,045,876 | 0.0% |
| Aimmune Therapeutics, Inc.(AIMT) | COM | 00900T107 | $10.1K | 673,908 | 0.0% |
| MacroGenics, Inc.(MGNX) | COM | 556099109 | $10.9K | 363,676 | 0.0% |
| Dermira, Inc.(DERMEUR) | COM | 24983L104 | $11.0K | 326,428 | 0.0% |
| Aerie Pharmaceuticals, Inc.(AERIEUR) | COM | 00771V108 | $11.3K | 299,356 | 0.0% |
| Zogenix, Inc. | COM NEW | 98978L204 | $11.4K | 1,000,000 | 0.0% |
| Alkermes plc(ALKS) | SHS | G01767105 | $11.8K | 250,251 | 0.0% |
| Vitae Pharmaceuticals, Inc. | COM | 92847N103 | $13.3K | 637,597 | 0.0% |
| BioMarin Pharmaceutical Inc. Notes 0.75% 10/15/2018 | NOTE 0.75% 10/15/2018 | 09061GAE1 | $14.6K | $12,228,000 | 0.0% |
| Mirati Therapeutics, Inc.(MRTXEUR) | COM | 60468T105 | $15.0K | 2,269,198 | 0.0% |
| TG Therapeutics, Inc.(TGTX) | COM | 88322Q108 | $15.5K | 2,003,991 | 0.0% |
| Galapagos NV(GLPG) | SPONSORED ADR | 36315X101 | $16.8K | 259,894 | 0.0% |
| Aegerion Pharmaceuticals, Inc. Notes 2.0% 8/15/2019 | NOTE 2.0% 8/15/2019 | 00767EAB8 | $17.4K | $26,517,000 | 0.0% |
| Derma Sciences, Inc. | COM PAR $.01 | 249827502 | $17.5K | 3,752,390 | 0.0% |
| Idera Pharmaceuticals, Inc. | COM NEW | 45168K306 | $18.0K | 7,014,015 | 0.0% |
| Intellia Therapeutics, Inc.(NTLA) | COM | 45826J105 | $18.1K | 1,062,120 | 0.0% |
| Sangamo BioSciences, Inc.(SGMO) | COM | 800677106 | $18.8K | 4,055,876 | 0.0% |
| Merus N.V. | COM | N5749R100 | $19.4K | 1,160,014 | 0.0% |
| bluebird bio, Inc. | COM | 09609G100 | $19.9K | 293,943 | 0.0% |
| Achillion Pharmaceuticals, Inc.(ACHNEUR) | COM | 00448Q201 | $20.1K | 2,475,515 | 0.0% |
| Halozyme Therapeutics, Inc.(HALO) | COM | 40637H109 | $20.9K | 1,731,057 | 0.0% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $21.4K | 872,072 | 0.0% |
| Array BioPharma Inc.(ARRYEUR) | COM | 04269X105 | $22.3K | 3,310,666 | 0.0% |
| Foamix Pharmaceuticals Ltd. | SHS | M46135105 | $22.8K | 2,466,702 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $23.1K | 3,650,808 | 0.0% |
| Versartis, Inc. | COM | 92529L102 | $26.1K | 2,134,247 | 0.0% |
| Advanced Accelerator Applications S.A. | SPONSORED ADR | 00790T100 | $39.2K | 1,029,247 | 0.0% |